Oncología médica
Especialidad
Nottingham University Hospitals NHS Trust
Nottingham, Reino UnidoPublikationen in Zusammenarbeit mit Forschern von Nottingham University Hospitals NHS Trust (1)
2018
-
Phase II study of buparlisib (BKM120) and trastuzumab in patients with HER2+ locally advanced or metastatic breast cancer resistant to trastuzumab-based therapy
Breast Cancer Research and Treatment, Vol. 168, Núm. 2, pp. 357-364